Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer
Conclusion In the second-line or later-line treatment, bevacizumab combined with chemotherapy is an effective and safe regimen for advanced non-squamous NSCLC.
DOI: 10.3779/j.issn.1009-3419.2018.07.02
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research
More News: Avastin | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | China Health | Genetics | Hypertension | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Study | Thrombocytopenia